Cryogenic Labels Companies and Competitive Landscape
The global cryogenic labels market size was evaluated at US$ 1.11 billion in 2023 and is expected to attain around US$ 2.16 billion by 2034, growing at a CAGR of 6.25% from 2025 to 2034.
Global Cryogenic Labels Market Key Players
Latest Announcements by Cryogenic Labels Industry Leaders:
- On October 17, 2024, Alma Clinical Services' Global Vice President of Operations, Donna Christopher, states an extremely intriguing chapter in contemporary medication development is represented by the market's ongoing rise for cell and gene therapy. Significant opportunities are presented by this expansion in a variety of therapeutic domains, including diabetes, autoimmune disorders, and oncology. Study success may be severely limited by the intricacy of managing international clinical trial supply chains containing highly volatile, valuable IMP.
New Advancements in Cryogenic Labels Industry
- In April, 2024, a new range of cryogenic multi-use dewars for the cell and gene therapy market was introduced by CSafe Company, a provider of active and passive temperature-controlled transportation solutions for the biopharmaceutical sector. The device, which is a component of Safe's CGT Cryo Series, keeps temperatures below -150°C. Critical cell and gene treatments, such as pre-frozen biologic materials, regenerative medicine, immunotherapies, stem cells, and CAR-T cells, can be safely transported with the use of the reusable dewars and high-impact-resistant shipping cases.
- In November, 2024, Custom Biogenic Systems (CBS), a Michigan-based maker of innovative cryogenic equipment, was purchased by Standex International Corporation (SI) for approximately $6.2 million in cash. As per the agreement, CBS will join SXI's scientific business division.
